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ACUPUNCTURE has a beneficial effect when treating
many diseases and painful conditions, and therefore
is thought to be useful as a complementary therapy
or to replace generally accepted pharmacological
intervention. The attributive effect of acupuncture
has been investigated in inflammatory diseases,
including asthma, rhinitis, inflammatory bowel dis-
ease, rheumatoid arthritis, epicondylitis, complex
regional pain syndrome type 1 and vasculitis. Large
randomised trials demonstrating the immediate and
sustained effect of acupuncture are missing. Mechan-
isms underlying the ascribed immunosuppressive
actions of acupuncture are reviewed in this commu-
nication. The acupuncture-controlled release of neu-
ropeptides from nerve endings and subsequent
vasodilative and anti-inflammatory effects through
calcitonine gene-related peptide is hypothesised. The
complex interactions with substance P, the analgesic
contribution of b-endorphin and the balance between
cell-specific pro-inflammatory and anti-inflammatory
cytokines tumour necrosis factor-a and interleukin-
10 are discussed.
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Introduction
In China, acupuncture has been used in the treatment
of several diseases for at least 5200 years. In Europe
and the USA, this integral part of traditional Chinese
medicine has become a visible component of the
health delivery system and has steadily claimed its
usefulness in complementary medicine. Although
sometimes without a clear objective beneficial effect,
an increasing number of patients, especially those
suffering from chronic diseases, are seeking acu-
puncture treatment and pursue (lay claims to) addi-
tional healthcare. Consequently, this increases costs,
even though it does not always provide a clear
objective beneficial effect.
1 The widespread applica-
tion of acupuncture includes the treatment of infec-
tions, inflammatory diseases like rheumatoid arthritis,
autonomic dysfunction, neurological diseases like
migraine, pain, cardiovascular diseases, pulmonary
diseases like asthma, drug abuse, psychological
disorders and many other illnesses.
2 Based on the
effects seen in this variety of diseases, acupuncture
could be divided into two main subjects: acupuncture
analgesia and curative acupuncture. In general,
analgesia is obtained by short-term acupuncture,
whereas curative acupuncture requires long-term
acupuncture treatment procedures. Traditional Chi-
nese acupuncture is characterised by a holistic
approach to the management of the disease. The
skill of the acupuncturist lies in the ability to work not
only with a clear-cut diagnosis, but also takes into
account the complex pattern of disease-related
factors. The exact pattern and degree of disharmony
is unique for each individual. Therefore, the practi-
tioner of traditional acupuncture will approach each
patient with a personalised treatment plan. This plan
focuses on improving the overall well-being of the
patient, rather than the isolated treatment of specific
symptoms or disease.
The basic health concept in traditional Chinese
medicine consists of the body’s vital energy (Qi),
circulating unidirectionally through a complex net-
work of channels (meridians) just beneath the skin,
but also moving within blood vessels. It permeates
organs and tissues, and is behind all physiological
processes. Health is the harmonious, uninterrupted
flow of Qi, and disease ensues when there is
disruption of Qi flow. Factors that can affect Qi
flow include emotional states such as anxiety, stress,
anger, fear or grief, poor nutrition, weather condi-
tions, hereditary factors, infections and trauma. By
inserting needles, the acupuncturist tries to recover
the equilibrium (the equal and dynamic opposite
qualities of Yin and Yang) between physical, emo-
tional and spiritual aspects of the individual, and to
improve energy flow and energy quality. Additional
activation can be obtained through manipulation of
the needle or electro-stimulation at different frequen-
cies. The most common manifestations of Yin and
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59Yang in diseases are excess and deficiency states.
Health is defined as the balance of Yin and Yang.
3
Improvement of local blood circulation, distribu-
tion and bloodletting could be the main aspects of
which acupuncture-derived effects in inflammatory
diseases could be attributed.
4 In the case of inflam-
mation, differential effects of acupuncture on acute
and chronic stages of the disease could be consid-
ered, more or less expressed by clinical symptoms
like burning pain, redness, swelling, changing tem-
perature and loss of function. Beyond these manifes-
tations, inflammatory mediators could represent
subsequential mechanisms that are involved, but
could also represent disease activity. For example,
in inflammatory bowel disease, the blood flow is
increased and vascular resistance diminished,
5
whereas the release of different inflammatory med-
iators is time and region dependent and could be
influenced by external factors.
6 8 In acupuncture, the
insertion of a needle induces marked changes close
to the needle in all the different tissues that are
penetrated. These peripheral events might improve
tissue function through vasodilatation in the skin due
to axon reflexes, which cause an immediate flare
reaction.
9 This vasodilative effect could be caused by
the release of calcitonin gene-elated peptide (CGRP)
upon stimulation of Ad or C fibres.
10,11 The local
release of b-endorphin could be responsible for the
short-term analgesic effect, whereas the neuropep-
tide-induced release of anti-inflammatory cytokines
could be derived from lymphocytes and secondary
activating cells, such as macrophages. In the periph-
ery, the real level of CGRP is of crucial importance.
Usually CGRP has been shown to be pro-inflamma-
tory, but in low doses it has a potent anti-inflamma-
tory action.
12 In this respect the release of another
neuropeptide, substance P, is not likely to attribute to
this phenomenon,
13 but could regulate CGRP release
from nerve endings.
14
In the present review, a hypothesis is presented
concerning the anti-inflammatory action of needle
acupuncture through a ‘dose’-related and time-re-
lated release of CGRP and a hypothesised preferential
shift to the subsequent formation of anti-inflamma-
tory cytokines.
Inflammatory diseases
In the following, a number of inflammatory diseases
will be reviewed in which acupuncture treatment was
initiated as a complementary therapy or replacement
for conventional pharmacological intervention. Then,
the role of mediators of inflammation in acupuncture
will be discussed and a proposed mechanism of
action to use acupuncture will be hypothesised.
Asthma
Numerous uncontrolled trials as well as a limited
number of controlled trials have been published with
contradictory and conflicting results after the short-
term or long-term use of acupuncture in the treat-
ment of asthma. In most studies, a relatively small
number of patients were included, whereas metho-
dological procedures were incompletely described.
Various outcome parameters such as lung function,
quality-of-life questionnaires and reduction of med-
ication were used to reflect improvement of the
disease.
The use of acupuncture to suppress the daily
intake of orally given corticosteroids and inhaled
b2-adrenergic agonists was investigated.
15 In an open
trial, patients with bronchial asthma were treated by
acupuncture. This resulted in a good therapeutic
effect (96% effective rate). Patients initially were
treated in 15 consecutive sessions and received 10
follow-up treatments to consolidate the curative
effect as marked by a decrease of corticosteroid
intake and diminished use of aerosols. The investi-
gator concluded that at least 30 sessions in 3 months
should be offered to initiate this effect, followed by
10 more sessions per year to prevent a relapse. The
extensive treatment with acupuncture could explain
the lack of effect seen in other studies.
In a double-blind cross-over study, the effect of 2
weeks of acupuncture treatment on patients with
stable asthma was investigated.
16 Although a signifi-
cant improvement of the quality of life and a
reduction of the usage of inhaled b2-adrenergic
agonists was observed, the respiratory function was
not affected. This is in contrast with another placebo-
controlled study in which patients with moderate
persistent asthma, who were only treated with
inhaled b2-adrenergic agonists, received a treatment
with acupuncture four times.
17 This relatively short
course of treatment did not affect daily intake of
inhaled b2-adrenergic agonists. No changes in lung
functions, bronchial hyper-reactivity or symptom
scores were observed.
In a randomised, controlled study, both the ad-
ditive effect of acupuncture to conventional therapy
and the immune-modulating effects on patients with
allergic asthma was monitored.
18 All patients were
treated 12 times for 30 min over a period of 4 weeks.
Subjective parameters like the patients’ general well-
being, and more objective parameters like biochem-
ical measurements in blood, were determined before
and after completion of the acupuncture treatment.
General well-being significantly improved in the
acupuncture group (79%) in comparison with the
control group (47%). Furthermore, lymphocyte pro-
liferation and CD3
  and CD4
  cells increased,
whereas the number of eosinophils significantly
decreased in the acupuncture group.
F. J. Zijlstra et al.
60 Mediators of Inflammation Vol 12  2003Single application of laser acupuncture performed
in a double-blind, placebo-controlled, crossover
study to investigate the protective effect on cold dry
air hyperventilation-induced bronchoconstriction re-
vealed no significant protection in paediatric and
adolescent patients.
19 Forced expiratory volume and
the expiratory flow were unaffected by single laser
acupuncture.
In 1991, Kleijnen et al. published a systematic
review of 13 controlled clinical trials pertaining to the
use of acupuncture in the treatment of asthma during
the period 1963 /1989.
20 Only three studies of
acceptable quality resulted in favourable effects.
Recently, other systemic reviews and meta-analyses
of all randomised clinical trials in the published
literature comparing acupuncture at real and placebo
points in asthmatic patients were performed. The
period 1970 /2000 was evaluated by Martin et al.
21
Peak expiratory flow rate, forced expiratory volume
and forced vital capacity were collected as objective
outcome parameters. In this analysis, no significant
overall effect of acupuncture to reduce asthma could
be confirmed. After induction of bronchoconstriction,
however, a significant effect was observed. The
authors concluded that this meta-analysis was limited
due to shortcomings of the individual trials and a not
clearly described use of sham acupuncture. Others
who reviewed the efficacy of acupuncture in asthma
concluded that up to now evidence is lacking, also
due to inadequately performed investigations.
22,23 In
conclusion, mainly based on clinical outcome para-
meters, there is presently not enough evidence to
make specific recommendations about the value of
acupuncture in the treatment of asthma (Table 1).
Rhinitis
Treatment by acupuncture is frequent among adults
with asthma and rhinosinusitis, and therefore should
be taken into account by health-care providers.
1,24 In
acute sinusitis, acupuncture resulted in an improve-
ment in children with chronic and recurring frontal
sinusitis.
25 In the treatment of seasonal allergic
rhinitis, acupuncture has been proven to be effective.
In a small single-blind crossover study, acupuncture
(three times a week during a 4-week period)
improved subjective symptom scores, although a
reduction in medication was not observed.
26 In
allergen-provoked rhinitis acupuncture, acupuncture
therapy was not effective when regarding the objec-
tive criteria, although again symptoms scores as
registered in the diary of complaints revealed a
reduction.
27 Desensitisation of allergic rhinitis using
acupuncture endermic points of the head with the
extract of positive allergens proved to be effective in
an open study including 102 cases. After a follow-up
of 2 years, a significant population (72%) showed a
curative effect, mainly reflected by a reduced dia-
meter of redness and reduced swelling of the skin.
28
In an open study, the positive effect of acupunc-
ture on atrophic rhinitis was demonstrated. The
improvement was documented by functional
changes of the nasal mucosa (mucociliary transport,
secreted volume and surface temperature).
29
Inflammatory bowel disease
The use of alternative medicine in bowel diseases
was already investigated almost two decades ago.
Significantly more patients with irritable bowel syn-
drome (11%) appeared to consult practitioners of
alternative medicine than patients with Crohn’s dis-
ease (4%).
30 Nowadays, traditional and complemen-
tary therapies such as acupuncture are more
frequently combined in the treatment, relief and
control of Crohn’s disease.
31 Until now, only limited
data is available for the complementary use of
acupuncture in ulcerative colitis with or without
moxibustion.
32 34 These data, however, indicate
that acupuncture could attribute to recovery in
patients with active inflammatory bowel disease.
Rheumatoid arhritis
In another autoimmune disease, rheumatoid arthritis,
which sometimes also results in the development of
Crohn’s disease, successful treatment with acupunc-
ture
35 and moxibustion has been reported.
36,37
Although the results clearly showed a beneficial
effect in the reduction of symptomatic pain, the small
sample size is a matter of concern.
In other placebo-controlled cross-over studies, in a
large number of patients with rheumatoid arthritis,
acupuncture could not attribute to any improvement
in general health, pain request or the examination of
the number of swollen joints, nor to a diminished
analgesic intake.
38,39
Until now, the usefulness of acupuncture as a
complementary and alternative medical therapy in
rheumatoid arthritis still has to be demonstrated in
large randomised trials.
40
Table 1. Summarised effects of acupuncture in inﬂammatory
diseases
Effect Reference
Asthma   //  / 15 /20
Rhinitis   / 25 /29
Ulcerative colitis   / 32 /34
Rheumatoid arthritis   //  / 35 /39
Epicondylitis   / 41 /46
Complex regional pain syndrome   / 49 /52
  /, Significant effect;   //  /, no clear disease-related effect.
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The clinical efficacy of acupuncture was also inves-
tigated in chronic lateral epicondylitis of the elbow
(tennis elbow). The immediate analgesic effect of a
single acupuncture stimulation in a placebo-con-
trolled single-blind trial has been reported.
41 In a
comparative study, both classical and superficial
needle insertion was studied in a short-term treat-
ment schedule stimulating five selected acupuncture
points during 10 treatments in 3 weeks.
42 Classical
acupuncture was only superior to superficial needle
insertion after all treatments were applied, but not at
3-month and 1-year follow-ups. Laser treatment
applied to the same acupuncture points, however,
did not improve subjective and objective outcome
parameters significantly in comparison with a pla-
cebo.
43 Psychosomatic factors could attribute signifi-
cantly in the positive short-term effects of pain
reduction.
44 As seen in the improvement of outcome
parameters including pain scores, function, disability,
strength and quality of life, short-term effects are
promising
45 but acupuncture failed to stabilise the
disease and did not contribute to further recovery.
46
Complex regional pain syndrome type 1
Recently, we confirmed that complex regional pain
syndrome type 1 (CRPS1), formerly indicated as post-
traumatic sympathetic dystrophy or Sudeck’s atrophy,
developed in one or more extremities, and should
also be considered as the result of an inflammatory
reaction after neurogenic stimulation.
47,48 Two case
reports
49,50 and two randomised trials predominantly
focused on pain reduction
51,52 have published im-
provements after long-term acupuncture treatment.
Other symptoms of inflammatory reactions including
swelling, mobility, temperature and redness were
also observed. In comparison with sham-treated
patients, no significant improvement of these para-
meters could be proven.
Vascular diseases
Inflammation of the vascular system could attribute to
some of the afore-described inflammatory diseases.
The promotion of blood circulation by acupuncture
could positively affect the enrolment of the whole
cascade of inflammatory mediators that are undoubt-
edly involved in the subsequent processes during
chronic inflammation.
53,54 In the context of migraine,
neurogenic inflammation could also play an impor-
tant role.
55 Elevated plasma levels of CGRP during
headache suggest that this initial inflammatory
mediator is involved. In general, acupuncture has
additional value in the treatment of primary head-
aches.
56,57
Inflammatory mediators
In general, inflammation is associated with increasing
temperature, oedema, redness, pain and loss of
function. Furthermore, the direct and indirect effects
of individual neuropeptides, cytokines and vasoac-
tive mediators
47 could be considered to play an
intermediate role during and after acupuncture has
been assessed. Assuming local blood flow is indeed
stimulated by acupuncture,
58,59 the neurogenic for-
mation of vasoactive mediators could regulate blood
flow and blood distribution to affected organs and
tissue after inflammation has been initiated. Acu-
puncture activates the defence systems. It influences
specific and non-specific cellular influx, activation of
cell proliferation and regulation of subsequently
involved cells that will result in a complex mechan-
ism of transport, further breakdown and clearance of
all bioactive mediators
60 (Table 2).
Neuropeptides
Calcitonine gene-related peptide is a potent vasodi-
lator
10 that has been shown to have a physiological
and pathological role in neurogenic inflammation,
migraine, thermal injury, circulatory shock, preg-
nancy and menopause, hypertension and heart fail-
ure, and has been proven to be cardioprotective.
61
Both substance P and CGRP have important roles in
oedema formation and inflammation, and when
transported centrally these neuropetides can cause
excitation.
62
In patients with CRPS1, blood samples did not
show an elevation of substance P and neurokinin A,
whereas neuropeptide Y, CGRP, bradykinin and
vasoactive intestinal peptide (VIP) were increased
four-fold.
63 Intraneural substance P contributes to the
severity of inflammation.
64 After intra-arterial infusion
in the human forearm, substance P provoked vaso-
dilatation, flushing and plasma extravasation.
65 In
musculocutaneous flaps in the rat, increased blood
flow affected by acupuncture was comparable with
the effects observed after injection of substance P and
Table 2. Inﬂammatory mediators reported in acupuncture
Neuropeptides Substance P
Neurokinin A
Neuropeptide Y
Vaso-active intestinal peptide
Bradykinin
Calcitonine gene related peptide
b-Endorphin
Cytokines IL-1b, IL-2, IL-4, IL-6, IL-10
IFN-g, TNF-a
Other vaso-active
substances
Nitric oxide
Eicosanoids
Serotonin
F. J. Zijlstra et al.
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59 In rats, acupuncture induced the release of
substance P from peripheral terminals of primary
sensory neurons.
66 After repeated electro-acupunc-
ture, significantly higher concentrations of substance
P and other neuropeptides such as neurokinin A and
neuropeptide Y were found in the rat brain.
67 The
acute release of neuropeptides can be mimicked and
easily provoked after application of capsaicin, the
bioactive substance of red pepper. Acupuncture
could diminish capsaicin-induced oedema in the rat
paw, indicating a prominent role for substance P and
other neuropeptides.
68 In dogs, the concentrations of
substance P were determined in the skin, muscle and
subcutis of acupoints and control points, showing an
increased release of substance P after acupuncture.
69
On the other hand, an observation in rabbit tooth
pulp showed that, after an initial substance P release
had already been evoked, electroacupuncture sup-
pressed this release.
70 In humans, during labour, the
content of substance P in serum declined after
acupuncture had been applied,
71 but increased in
patients suffering from fibromyalgia.
72 In both ob-
servations the analgesic effect of acupuncture was
significant. In samples taken from the saliva of
healthy subjects, the release of substance P was
hardly affected after acupuncture, although neuro-
peptide Y and CGRP were markedly increased.
73
Needling of acupuncture points could result in
activation of afferent fibres of peripheral nerves,
which induces the release of endogenous opiate
peptides from nerve cells. Beta-endorphins are
believed to play an important intermediate role in
the regulation of the analgesic effects obtained
through acupuncture.
74,75 Beta-endorphin concentra-
tions in spinal fluid and plasma of horses, however,
were not elevated after acupuncture.
76 Although
prenatal acupuncture treatment in women signifi-
cantly reduced the duration of labour, serum levels of
b-endorphin were not influenced.
77 In another study,
however, 90 patients suffering from various painful
disorders were subjected to acupuncture. Plasma b-
endorphin levels were increased considerably in-
crease, resulting in an elevated immunologic re-
sponse
78 reflected by lymphocyte markers CD3,
CD4 and CD8.
In curative (long-term) acupuncture, interactions
between b-endorphins and cytokines could therefore
result in an increased formation of anti-inflammatory
cytokines
79 such as interleukin (IL)-10 and/or a
diminished production of pro-inflammatory cyto-
kines, possibly being the most prominent mechanism
of action underlying the attributive effect of acupunc-
ture in chronic inflammatory diseases. Very recently,
the existence of regulatory IL-10-dependent T-cell
populations was documented in allergic diseases.
80
Cytokines
Recently, the effect of acupuncture on regulation of
cytokine production in asthma has been published.
81
Clinical signs of asthma improved markedly. In
peripheral blood of asthmatic patients, the mean IL-
2 and IL-6 plasma levels were decreased, whereas
interferon (IFN)-g, IL-4 and tumour necrosis factor
(TNF)-a were increased. After acupuncture IFN-g,I L -
2, IL-4 and IL-6 were elevated and TNF-a was
reduced. In allergic rhinitis, plasma concentrations
of IL-2, IL-6 and IL-10 were determined before and
after acupuncture in comparison with healthy con-
trols.
82 In all allergic rhinitis patients, IL-10 levels
were increased prior to real acupuncture, sham
acupuncture or non-treatment. In the acupuncture
group IL-10 was reduced, whereas IL-2 was hardly
affected and IL-6 remained unchanged after therapy.
In rheumatoid arthritis, IL-2 levels were lower than in
the healthy controls.
36,37 After acupuncture, this
reduced IL-2 production was elevated. In a rat model
for ulcerative colitis,
83 acupuncture and moxibustion
inhibited the expression of pro-inflammatory cyto-
kines IL-1b and IL-6.
In conclusion, the (im)balance between T helper 1
cell-derived and T helper 2 cell-derived pro-inflam-
matory and anti-inflammatory cytokines was reset by
acupuncture.
Nitric oxide
As some observations highlight the stimulating effects
of acupuncture to muscle afferents and blood flow
through autonomic reflexes, the attributive effect of
nitric oxide (NO) through local release and/or
induction after electrostimulation should also be
considered.
84 Significant and persistent increases in
the arteriolar diameter were observed after electro-
acupuncture. This effect was abolished in the pre-
sence of nitro-L-arginine methyl ester (L-NAME),
indirectly indicating that NO plays a key role in the
primary mechanisms that are involved in microcircu-
lation. From rat studies, it has been shown that NO
levels were increased in rat striatum after cerebral
artery occlusion, ischaemia and reperfusion. Electro-
acupuncture antagonised the ischaemia-elicited re-
lease of NO.
85 The anticonvulsant effect of electro-
acupuncture might be related to the decrease of the
nitric oxide synthases neuronal nitric oxide synthase
and inducible nitric oxide synthase.
86 From these
preliminary results it is not clear whether central
effects evoked by electro-acupuncture are more
pronounced than those observed in the circulatory
system, especially when inflammation occurs and the
endothelial-derived nitric oxide synthase produces
sustained amounts of NO.
87 Furthermore, a disturbed
microcirculation through shunting of arterioles is also
evoked by serotonin, another reasonable explanation
Anti-inflammatory actions of acupuncture
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Discussion
Pitfalls in methodology of measuring the use of
acupuncture
In general, acupuncture trials include a limited
number of patients. These trials are heterogeneous
regarding patients, interventions and outcome mea-
sures and (therefore) present contradictory results.
Most obvious is the need for well-designed and larger
clinical trials.
88 Research in the area of complemen-
tary medicine such as acupuncture should be per-
formed and evaluated at the same high-quality
standards as research in the use of conventional
therapies. In some studies, acupuncture points that
were used in the sham groups could be effective
according to traditional Chinese medicine. Therefore,
with regard to the standardised choice of acupunc-
ture points in the set-up of repeatedly applied
acupuncture in sham acupuncture controlled clinical
trials, the main problem to be solved is to determine
the originally individualised treatment strategy that
includes this approach.
A matter of debate is the set-up of randomised
trials comparing placebo, sham or non-treatment. A
placebo needle has been designed, with which it
could be possible to stimulate an acupuncture
procedure without penetrating the skin.
89 In this
set-up, placebo-treated patients experienced less Qi
pain sensation, also expressed by a diminished visual
analogue scale pain. Another acceptable approach
could be the inclusion of sham laser acupuncture,
90
but it is preferred that sham acupuncture is used,
when not actively involved meridians are needled or
superficial pricking is applied. Based on functional
magnetic resonance imaging of the whole brain, it
has however been demonstrated that superficial
pricking revealed more signal intensity than minimal
applied acupuncture.
91
From a pharmacotherapeutical point of view
(kinetics, dynamics and dose finding), it is difficult
to make comparisons between different acupuncture
techniques that are used in not well-described
studies. First, from traditional Chinese medicine,
acupuncture should be considered and applied as
an individually based therapy. Many factors and
variables will influence the outcome of the therapy,
such as: which of the acupoints and how many
acupoints are chosen per treatment session? what is
the reproducibility of the matrix of chosen acupoints?
what is the type, depth, direction and manipulation
of the inserted needle? what is the needle retention
time and the length of the session? what is the
frequency and total number of treatments? what is
the follow-up? and what are the maintenance
treatments?
92 (Table 3) Furthermore, for Western
scientists, the main part of the literature describing
Chinese and Japanese trials performed on acupunc-
ture is only available as translated abstracts. Not only
is there a marked difference between Chinese and
Japanese acupuncture, but Western educated and
qualified acupuncturists apply acupuncture differ-
ently in comparison with ancient acupuncturists. In
some studies performed in Western countries, Chi-
nese guest scientists collaborated in these studies,
and they were the ones who performed the acu-
puncture treatments during their stay. As a conse-
quence, some specific methodological information is
missing, which makes it virtually impossible to
continue or repeat treatment schedules for specific
purposes (Fig. 1). Recently, standards for reporting
the outcome of controlled acupuncture trials have
been published.
93 96 Because the intensity and
frequency of acupuncture as a complementary ther-
apy will be individually chosen, one should also
consider the subtype of the disease. In asthma, for
instance, some aspects such as allergic, acute,
chronic, exercise or cold-induced asthma should be
considered, which will certainly affect the outcome of
the acupuncture therapy. In most studies, subjective
parameters (e.g. visual analogue scale pain, life
questionnaires) are used. In open and single-blinded
trials, the results clearly depend on the sample size
and the number of repeated measurements. Objec-
Table 3. Variables in acupuncture
Controlled studies Non-treated controls
Placebo needled acupuncture
Sham (non) invasive acupuncture
Laser
Superficial (‘minimal’)
‘Wrong’ acupoints
Penetrating/invasive acupuncture
Disease-related acupuncture
Individualised acupuncture
Style Chinese traditional acupuncture
Japanese superficial acupuncture
Western-oriented acupuncture
Treatment schedule Single treatment
Frequency
Repeated treatments short term
Repeated treatments long term
Follow-up treatment
Needle Point selection per session
Number of acupoints used
Number of needles inserted
Depth of insertion, needle type
Duration of needling
Stimulation Manual
Electrical
Blinding Patient
Acupuncturist
Physiotherapist
Assessor
Statistician
Co-interventions Moxibustion
Herbs
Physical therapy
Pharmaceutical intervention
F. J. Zijlstra et al.
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second (FEV1), oedema or secreted volume and
surface temperature) better reflect the attributive
effect of acupuncture in the recovery from inflam-
matory diseases, but do not distinguish between
primary and secondary events. Therefore, documen-
ted research on underlying mechanisms indicating
the specific release or inhibitory action on the
formation of inflammatory mediators such as sub-
stance P, CGRP, b-endorphin and cytokines would
undoubtedly indicate whether acupuncture is advi-
sable as a complementary therapy and confirm
preliminary results.
Mechanism of action of acupuncture: a concept
The underlying mechanism of acupuncture could be
that, after antidromic stimulation of the nociceptor,
CGRP, substance P and b-endorphin are all released.
Initially, substance P will activate mast cells and in a
later phase also macrophages to secrete inflammatory
mediators. As a consequence, the mast cell will not
only secrete serotonin and histamine, but also
cytokines such as TNF-a. In turn, TNF-a could prime
sensory nerve endings.
97 The activation of mast cells
and mast cell-mediated inflammation is regulated by
NO.
98 Macrophages will produce a number of
cytokines and eicosanoids. In the blood vessel,
CGRP will directly or indirectly affect vasodilation
and extravasation via the stimulation of NO,
99,100 VIP
and bradykinin. Delayed dilatation to bradykinin is
cyclooxygenase-2 dependent,
101 whereas prostaglan-
din E2 potentiates bradykinin and induces pain.
Substance P regulates the vasodilator activity of
CGRP through the action of proteases from mast
cells.
14 In calcitonin/alpha calcitonin gene-related
peptide knockout mice, nociceptive hypersensibility
was reduced.
102 Furthermore, it has been shown that
both CGRP and VIP counteract nicotine-induced
sweating.
103 The suppressing or potentiating effects
of substance P and CGRP on metacholine-mediated
cholinergic sweating, however, were dose depen-
dent.
104,105 The ability of sweating to regulate skin
temperature is well known and is more pronounced
in men than in women. In women with chronic
pelvic pain, intravenous infusion with CGRP resulted
in a significant increase of skin temperature and
complaints in comparison with healthy volunteers,
whereas VIP did not provoke pain nor affect tem-
perature,
106 suggesting the existence of a neurovas-
cular disorder. There has been some evidence that
hot flashes observed in menopausal women are due
to up-regulation of CGRP receptors following ovarian
hormone deficiency.
107 In ovariectomised rats, the
greatest vasodilation and skin temperature increase
was observed after CGRP, with less effect of VIP and
the smallest effect seen after substance P.
108 In men
who showed hot flashes after castration due to
prostate carcinoma, plasma CGRP levels were ele-
vated.
109 These results suggest that the vasodilative
and skin temperature increasing effect of CGRP could
be due to a diminished amount of (female) sex
steroids. This could explain the higher incidence of
migraine in woman
110 and menstrual-related mi-
graine,
55,111 and the prevalence of some diseases in
women, such as CRPS1
47,48 and carpal tunnel syn-
drome.
112 In addition, studies on gender differences
in pressure pain threshold in healthy humans showed
a significant decrease in females in comparison with
males.
113
In general, the acute, short-term and long-term
effects of acupuncture are comparable with actions
observed by the use of capsaicin. Capsaicin is the
bioactive component of chili pepper. Application of
capsaicin to the skin
114 116 or mucous membranes
117
initially results in irritation and hyperaesthesia. This
momentary effect is attributed to the release of
substance P from peripheral sensory C fibres. Re-
peated application of capsaicin would result in a
depleted secretion of substance P from neurons.
During inflammation these effects are more pro-
nounced.
118 It is conceivable that the simultaneous
release of CGRP will follow the same cascade of
secretion. The antinociceptive effects of a capsaicin
analogue, civamide, when given orally to rats, have
been described.
119 Besides the receptor related
effects of this vanilloid receptor agonist and neuronal
calcium channel blocker, proposed actions could also
include inhibition of the neuronal release of CGRP
and substance P.
120 That could explain the acute
120
and prophylactic properties
121 of this substance in
the treatment of cluster headaches. In concordance
with these findings, therapeutic (needle) acupunc-
ture induces peripheral events that might improve
tissue function and induce local pain relief, based on
mechanisms that include axon reflexes, release of
neuropepties such as CGRP, anti-inflammatory ac-
tions of neuropeptides like substance P, and local
release of b-endorphin. Furthermore, sympathetic
FIG. 1. A number of studies describing the application of
acupuncture in inﬂammatory disease have been published.
Conclusions are difﬁcult to be made, due to different
acupuncture techniques used and insufﬁciently described
methodology. (Drawing by Theodoor van Baars.)
Anti-inflammatory actions of acupuncture
Mediators of Inflammation Vol 12  2003 65inhibition could occur and levels of stress hormones
and sex steroids could be reduced. Intense and
frequently applied acupuncture gives rise to more
pain, which could be due to high amounts of
secreted CGRP (comparable with initial effects of
capsaicin) when the inflammatory effect is predomi-
nant. Pain relief sometimes is observed after some
days of treatment, possibly due to the delayed release
of b-endorphins and the accumulated dose needed to
be effective
2 through IL-10 formation.
79,122 124 IL-10
formation is limited, as has been shown in IL-10-
dependent T-cell populations.
80
As already stated in the Introduction, high levels of
CGRP have been shown to be pro-inflammatory but,
on the contrary, CGRP in low concentrations exerts
potent anti-inflammatory actions.
12 The main attribu-
tive effect of substance P could be the feedback
regulation of CGRP release from nerve endings.
13,14
The effects of neuropeptides may vary from one
organ or tissue to another. The presence and time-
dependent contribution of mast cells, macrophages
and other inflammatory cells to produce mediators
that activate or counteract the inflammatory process
may be of crucial importance
125 (Fig. 2). Therefore, a
well-performed and frequently applied ‘low-dose’
treatment of acupuncture could provoke a sustained
release of CGRP with anti-inflammatory activity,
without stimulation of pro-inflammatory cells. That
could be the explanation why acupuncture only
seems to be beneficial in the treatment of some
inflammatory conditions.
FIG. 2. Schematic overview of proposed interplay between nerve cells and inﬂammatory cells, and site of action of
acupuncture and capsaicin or antagonists: role of neuropeptides, cytokines, nitric oxide and eicosanoids. NOS, Nitric oxide
synthase; SP, substance P; Th, T helper.
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A number of observations on the anti-inflammatory
actions of acupuncture have been published, repre-
senting open studies and randomised trials. Both
short-term and long-term treatment schedules were
performed, with varying number of acupuncture
points, acupuncture frequency and additional appli-
cation of electro-stimulation. The value of comple-
mentary acupuncture in the treatment of
inflammatory diseases is still questioned. In asthma,
the highest effective rate observed was obtained after
a high number of frequently applied acupuncture
sessions were performed, then reduced, and then
performed at least 10 times per year to prevent
relapse.
15 In rhinitis, results that were mainly ob-
tained from open trials suggest a complementary
effect of acupuncture after allergen provocation. In
inflammatory bowel disease and rheumatoid arthritis,
the usefulness of acupuncture still has to be demon-
strated in large randomised trials. In epicondylitis and
CRPS1, the attributive immunosuppressive effect of
acupuncture has not yet been properly investigated,
although a reduction of pain has been observed.
From preliminary results it is conceivable to hypothe-
sise that CGRP has a prominent role in the acupunc-
ture-affected regulation of acute, sub-acute and
chronic inflammation, regarding the vasodilative
properties of this neuropeptide. Substance P should
be considered to counteract the release of CGRP from
nerve endings, whereas the balance of the mast cell
derived pro-inflammatory TNF-a and the T-cell-
derived anti-inflammatory IL-10 could contribute to
the development of the chronic stage of the inflam-
mation. In this respect, acupuncture as a maintenance
treatment could be beneficial to reduce inflammation.
Evidence from large randomised trials, including
follow-up measurements of mediators of inflamma-
tion, both at the site of inflammation and in the
periphery, should be obtained to prove the immu-
nologic effects of acupuncture.
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